CD274 and breast carcinoma: By activating the PD-1/PD-L1 signal pathway, PD-L1 suppresses immune cells’ surveillance and cytotoxic activity, promoting the occurrence, development, and escape of malignant tumor cells, such as lung, liver, and breast cancers (15–17).